HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

INSILICO

65.550

-2.750-4.03%

Volume:2.51M

Turnover:166.08M

Market Cap:37.47B

PE:-275.42

High:70.000

Open:68.300

Low:63.500

Close:68.300

52wk High:80.900

52wk Low:29.980

Shares:571.62M

HK Float Shares:571.62M

Volume Ratio:1.11

T/O Rate:0.44%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-0.238

ROE:--

ROA:--

PB:-7.03

PE(LYR):-275.42

PS:89.36

Loading ...

Overview Company News Filings

Assessing InSilico Medicine Cayman TopCo (SEHK:3696) Valuation After Strong Year To Date Share Price Gains

Simply Wall St.

InSilico Medicine to Join Hang Seng Index

MT Newswires Live

Hong Kong Stock Announcement Highlights: Insilico, Seyond, and CF Pharmtech Added to Hang Seng Composite Index Constituents

InSilico Medicine (3696) Selected for Inclusion in Hang Seng Composite Index

Bulletin Express

INSILICO to Join Hang Seng Composite Index Constituents

Insilico Medicine Cayman TopCo Joins Hang Seng Composite IndexInsilico Medicine Cayman TopCo said it has been selected for inclusion in the Hang Seng Composite Index, effective March 9, 2026. The company added that the move is expected to help its shares meet eligibility criteria for trading via the Shanghai-Hong Kong Stock Connect and the Shenzhen-Hong Kong Stock Connect

Insilico Medicine CMS Alliance Tests Investor Faith In AI Drug Pipeline

Simply Wall St.

Assessing InSilico Medicine Cayman TopCo (SEHK:3696) Valuation After A Strong Momentum-Driven Share Price Rally

Simply Wall St.

BUZZ-InSilico hits fresh high on partnership deal with China Medical

Insilico Medicine Enters Drug Development Partnership With China Medical System

MT Newswires Live

InSilico Medicine (3696.HK) and CMS (867.HK) Announce AI-Focused Drug Development Partnership

Bulletin Express

Insilico Partners with CMS on Multi-Million-Dollar AI-Driven Drug Development for CNS and Autoimmune Disorders

Insilico Medicine Cayman Topco startet Milliarden-Kooperation mit CMS zur Entwicklung von Medikamenten für das zentrale Nervensystem und Autoimmunerkrankungen

Insilico Medicine Cayman Topco - Deal to Collaborate Across Multiple Projects in Fields of Central Nervous System, Autoimmune Diseases

THOMSON REUTERS

Insilico Medicine Cayman Topco - Also Expected to Receive R+D Funding Support of up to Several Tens of Millions of HKD for Each Program

THOMSON REUTERS

Insilico Medicine Cayman Topco - Insilico Medicine and CMS Enter Into Drug Development Collaboration

THOMSON REUTERS

Insilico Medicine ernennt Halle Zhang zur Vizepräsidentin für klinische Entwicklung in der Onkologie

Insilico Medicine Appoints Halle Zhang, Phd (Med), as Vice President, Clinical Development - Oncology

THOMSON REUTERS

Insilico Medicine nominiert ISM5059 als neuen NLRP3-Hemmer für Entzündungstherapien

Insilico Medicine Nominates ISM5059, the Peripheral-Restricted Nlrp3 Inhibitor as Preclinical Candidate, for the Treatment of Multiple Inflammatory and Metabolism Indications

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/03696/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"03696","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"03696\",,,,,undefined,":{"symbol":"03696","market":"HK","secType":"STK","nameCN":"INSILICO","latestPrice":65.55,"timestamp":1771920489007,"preClose":68.3,"halted":0,"volume":2505761,"delay":0,"changeRate":-0.04026354319180088,"floatShares":571622000,"shares":571622000,"eps":-0.238,"marketStatus":"Not Yet Opened","change":-2.75,"latestTime":"02-24 16:08:09","open":68.3,"high":70,"low":63.5,"amount":166084296,"amplitude":0.095168,"askPrice":65.55,"askSize":2500,"bidPrice":65,"bidSize":1500,"shortable":3,"etf":0,"ttmEps":-0.624,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1771983000000},"marketStatusCode":0,"adr":0,"listingDate":1767024000000,"exchange":"SEHK","adjPreClose":68.3,"openAndCloseTimeList":[[1771896600000,1771905600000],[1771909200000,1771920000000]],"volumeRatio":1.1106124704252174,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"03696\",,,,,undefined,":{"symbol":"03696","floatShares":571622000,"roa":"--","roe":"--","lyrEps":-0.238,"volumeRatio":1.1106124704252174,"shares":571622000,"dividePrice":0,"high":70,"amplitude":0.095168,"preClose":68.3,"low":63.5,"week52Low":29.98,"pbRate":"-7.03","psRate":"89.36","week52High":80.9,"institutionHeld":0,"latestPrice":65.55,"committee":-0.25,"eps":-0.238,"divideRate":0,"volume":2505761,"delay":0,"ttmEps":-0.624,"open":68.3,"prevYearClose":37.14,"prevWeekClose":73.3,"prevMonthClose":62.9,"prevQuarterClose":37.14,"fiveDayClose":73.65,"twentyDayClose":58.9,"sixtyDayClose":24.05},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/03696\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"03696\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"03696\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1771862400000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/03696\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"03696","date":"2026-02-23","current":-105.048077,"percent":0.222222,"low":-126.474328,"twenty":-113.283895,"median":-97.098426,"eighty":-72.901197,"high":-38.773669,"avg":-93.131099,"sd":22.247951,"marketCap":38928718780},"quantilePoints":[{"date":"2026-01-02","current":-60.518922,"twenty":-60.091977,"median":-54.070713,"eighty":-44.509914,"marketCap":20885577298},{"date":"2026-01-09","current":-75.603624,"twenty":-68.00457,"median":-60.518922,"eighty":-55.21804,"marketCap":26120865700},{"date":"2026-01-16","current":-88.730045,"twenty":-88.029114,"median":-68.708073,"eighty":-60.032461,"marketCap":30678123120},{"date":"2026-01-23","current":-103.197987,"twenty":-90.498742,"median":-83.671368,"eighty":-60.384368,"marketCap":35679909160},{"date":"2026-01-30","current":-103.586135,"twenty":-97.608242,"median":-87.528966,"eighty":-61.04227,"marketCap":35850899140},{"date":"2026-02-06","current":-102.242154,"twenty":-102.624487,"median":-88.730045,"eighty":-63.670801,"marketCap":35423424190},{"date":"2026-02-13","current":-120.862692,"twenty":-111.02361,"median":-93.674734,"eighty":-69.411577,"marketCap":41892545100},{"date":"2026-02-20","current":-120.573146,"twenty":-113.535701,"median":-95.532684,"eighty":-72.22559,"marketCap":41778551780},{"date":"2026-02-23","current":-112.276672,"twenty":-113.283895,"median":-97.098426,"eighty":-72.901197,"marketCap":38928718780}],"updateTime":1771961069088},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"03696\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2614582747","title":"Assessing InSilico Medicine Cayman TopCo (SEHK:3696) Valuation After Strong Year To Date Share Price Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2614582747","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614582747?lang=en_us&edition=fundamental","pubTime":"2026-02-25 01:26","pubTimestamp":1771954001,"startTime":"0","endTime":"0","summary":"InSilico Medicine Cayman TopCo (SEHK:3696), an AI focused biotech group, has drawn fresh attention after a recent month of positive share performance, in contrast with weaker daily and past week returns that may interest short term traders.\nSee our latest analysis for InSilico Medicine Cayman TopCo.\nThat recent 4.71% 30 day share price return, despite a 1 day decline of 4.03% and a 7 day share price return of negative 14.76%, sits against a much stronger 74.43% year to date share price return...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3696/insilico-medicine-cayman-topco-shares/news/assessing-insilico-medicine-cayman-topco-sehk3696-valuation-4","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3696/insilico-medicine-cayman-topco-shares/news/assessing-insilico-medicine-cayman-topco-sehk3696-valuation-4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4587","BK4585","BK1141","BK4528","BK4588","AI","03696","AIYY","BK4023","BK4543","BK4551"],"gpt_icon":0},{"id":"2612210237","title":"InSilico Medicine to Join Hang Seng Index","url":"https://stock-news.laohu8.com/highlight/detail?id=2612210237","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612210237?lang=en_us&edition=fundamental","pubTime":"2026-02-20 09:36","pubTimestamp":1771551410,"startTime":"0","endTime":"0","summary":"InSilico Medicine (HKG:3696) said it was due to join the Hang Seng Composite Index on March 9, according to a Hong Kong bourse filing Friday.The AI-driven drug discovery and development company listed on the Hong Kong bourse in December last year.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1141","03696"],"gpt_icon":0},{"id":"1157516521","title":"Hong Kong Stock Announcement Highlights: Insilico, Seyond, and CF Pharmtech Added to Hang Seng Composite Index Constituents","url":"https://stock-news.laohu8.com/highlight/detail?id=1157516521","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157516521?lang=en_us&edition=fundamental","pubTime":"2026-02-20 09:18","pubTimestamp":1771550300,"startTime":"0","endTime":"0","summary":"【Major Developments】Insilico (03696) has been added as a constituent of the Hang Seng Composite Index. Seyond (02665) has been added as a constituent of the Hang Seng Composite Index. CF Pharmtech...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","VT","03696","02498","BK1144","BK1589","BK1191","03692","HSCI","02652","02665","BK1179","BK4585","BK1141","VXUS","BK4588"],"gpt_icon":0},{"id":"1158327840","title":"InSilico Medicine (3696) Selected for Inclusion in Hang Seng Composite Index","url":"https://stock-news.laohu8.com/highlight/detail?id=1158327840","media":"Bulletin Express","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158327840?lang=en_us&edition=fundamental","pubTime":"2026-02-20 08:24","pubTimestamp":1771547059,"startTime":"0","endTime":"0","summary":"InSilico Medicine Cayman TopCo (“Insilico Medicine” or “the Company”) has been chosen by Hang Seng Indexes Company Limited to become a constituent stock of the Hang Seng Composite Index (“HSCI”),...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"gpt_icon":0},{"id":"1199659849","title":"INSILICO to Join Hang Seng Composite Index Constituents","url":"https://stock-news.laohu8.com/highlight/detail?id=1199659849","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199659849?lang=en_us&edition=fundamental","pubTime":"2026-02-20 08:06","pubTimestamp":1771545973,"startTime":"0","endTime":"0","summary":"INSILICO (03696) announced that the company has been selected by Hang Seng Indexes Company and will be included as a constituent of the Hang Seng Composite Index, effective from March 9, 2026....","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HSCI","03696","BK1141"],"gpt_icon":0},{"id":"2612234108","title":"**Insilico Medicine Cayman TopCo Joins Hang Seng Composite Index**Insilico Medicine Cayman TopCo said it has been selected for inclusion in the Hang Seng Composite Index, effective March 9, 2026. The company added that the move is expected to help its shares meet eligibility criteria for trading via the Shanghai-Hong Kong Stock Connect and the Shenzhen-Hong Kong Stock Connect","url":"https://stock-news.laohu8.com/highlight/detail?id=2612234108","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612234108?lang=en_us&edition=fundamental","pubTime":"2026-02-20 08:00","pubTimestamp":1771545642,"startTime":"0","endTime":"0","summary":"**Insilico Medicine Cayman TopCo Joins Hang Seng Composite Index** Insilico Medicine Cayman TopCo said it has been selected for inclusion in the Hang Seng Composite Index, effective March 9, 2026. The company added that the move is expected to help its shares meet eligibility criteria for trading via the Shanghai-Hong Kong Stock Connect and the Shenzhen-Hong Kong Stock Connect. Insilico Medicine Cayman TopCo said it will be **added** as a constituent of the **Hang Seng Composite Index** effective **March 9, 2026**. The company said the inclusion reflects the market’s recognition of its industry position, business performance and value, and is expected to improve share liquidity and broaden its investor base.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investmen","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260220:nNDL8syV4H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696","BK1141"],"gpt_icon":0},{"id":"2612512405","title":"Insilico Medicine CMS Alliance Tests Investor Faith In AI Drug Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2612512405","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612512405?lang=en_us&edition=fundamental","pubTime":"2026-02-19 13:31","pubTimestamp":1771479062,"startTime":"0","endTime":"0","summary":"Insilico Medicine Cayman TopCo announced a new partnership with China Medical System Holdings SEHK:3696 to collaborate on AI powered drug discovery and development.\nThe company also nominated ISM5059, an NLRP3 targeted drug candidate discovered using its AI platform, for preclinical development.\nThese updates follow recent FDA IND approval for another AI created drug in Insilico Medicine's pipeline.\n\nFor you as an investor, these moves sit at the intersection of AI and pharmaceuticals, where...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3696/insilico-medicine-cayman-topco-shares/news/insilico-medicine-cms-alliance-tests-investor-faith-in-ai-dr","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3696/insilico-medicine-cayman-topco-shares/news/insilico-medicine-cms-alliance-tests-investor-faith-in-ai-dr","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0949170772.SGD","BK4208","LU1894683264.USD","LU0553294199.USD","LU0545039389.USD","BK4587","LU0738911758.USD","CMS","BK4588","LU1003077747.HKD","BK4551","BK4543","03696","BK4585","LU2637428348.USD","BK4528","BK4023","LU0661504455.SGD","LU1894683348.USD","LU2500361329.USD","AI","BK1141","LU2346227817.USD"],"gpt_icon":0},{"id":"2611217549","title":"Assessing InSilico Medicine Cayman TopCo (SEHK:3696) Valuation After A Strong Momentum-Driven Share Price Rally","url":"https://stock-news.laohu8.com/highlight/detail?id=2611217549","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611217549?lang=en_us&edition=fundamental","pubTime":"2026-02-16 04:19","pubTimestamp":1771186776,"startTime":"0","endTime":"0","summary":"Why InSilico Medicine Cayman TopCo is on investors’ radar\nInSilico Medicine Cayman TopCo (SEHK:3696) has recently caught attention after a strong share price move, including an 18.3% return over the past week and 33.3% over the past month.\nSee our latest analysis for InSilico Medicine Cayman TopCo.\nThe recent jump in InSilico Medicine Cayman TopCo’s share price, with a 7 day share price return of 18.3% and 30 day share price return of 33.3%, sits within a much stronger year to date share...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3696/insilico-medicine-cayman-topco-shares/news/assessing-insilico-medicine-cayman-topco-sehk3696-valuation-3","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3696/insilico-medicine-cayman-topco-shares/news/assessing-insilico-medicine-cayman-topco-sehk3696-valuation-3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4588","BK1141","BK4528","BK4585","BK4023","BK4543","03696","BK4551","AI","BK4587"],"gpt_icon":0},{"id":"2610696513","title":"BUZZ-InSilico hits fresh high on partnership deal with China Medical","url":"https://stock-news.laohu8.com/highlight/detail?id=2610696513","media":"Reuters","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610696513?lang=en_us&edition=fundamental","pubTime":"2026-02-10 10:17","pubTimestamp":1770689824,"startTime":"0","endTime":"0","summary":"BUZZ-InSilico hits fresh high on partnership deal with China Medical.** Shares of InSilico Medicine Cayman TopCo 3696.HK jump 9.9% to HK$73.8, a fresh high since their debut on December 30, 2025** Stock on track for biggest daily gain since February 3; on track for second session of rise** InSilico says it has entered into a strategic partnership with China Medical System 0867.HK on innovative drug development in the fields of central nervous system and autoimmune diseases** Insilico says the two parties will jointly advance the co-development of no fewer than two R&D programs** The company is expected to receive R&D funding support of up to several tens of millions of Hong Kong dollars for each program** Shares of China Medical System slip 2% ** Insilico stock has soared 202% from the HK$24.05 IPO price in nearly 6 weeks** YTD, Insilico shares up 92.5%, Hang Seng Biotech Index .HSBIO up 11.3%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260210:nL1N3Z601U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BVYPNP33.GBP","LU2488822045.USD","BK1191","00867","BK1593","BK1141","03696","SG9999004220.SGD","IE00BMCWC346.EUR","SG9999015952.SGD","SG9999015986.USD","IE00BGHQDM52.EUR","IE00BVYPNQ40.USD","SG9999015978.USD","SG9999015945.SGD","IE00BYV24P56.USD"],"gpt_icon":0},{"id":"2610693787","title":"Insilico Medicine Enters Drug Development Partnership With China Medical System","url":"https://stock-news.laohu8.com/highlight/detail?id=2610693787","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610693787?lang=en_us&edition=fundamental","pubTime":"2026-02-10 09:38","pubTimestamp":1770687485,"startTime":"0","endTime":"0","summary":"Insilico Medicine  said it entered a drug development partnership with China Medical System , according to a Hong Kong bourse filing Tuesday.Under the agreement, the two sides will collaborate to co-develop at least two drugs.Insilico Medicine is expected to receive R&D funding support of up to \"several tens of millions of HKD\" for each program.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK6079","IE00BVYPNP33.GBP","IE00BVYPNQ40.USD","00867","8A8.SI","SG9999015952.SGD","BK1191","IE00BYV24P56.USD","SG9999015945.SGD","BK1141","LU2488822045.USD","SG9999015978.USD","BK1593","IE00BMCWC346.EUR","SG9999004220.SGD","IE00BGHQDM52.EUR","03696","SG9999015986.USD"],"gpt_icon":0},{"id":"1185193421","title":"InSilico Medicine (3696.HK) and CMS (867.HK) Announce AI-Focused Drug Development Partnership","url":"https://stock-news.laohu8.com/highlight/detail?id=1185193421","media":"Bulletin Express","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185193421?lang=en_us&edition=fundamental","pubTime":"2026-02-10 08:21","pubTimestamp":1770682904,"startTime":"0","endTime":"0","summary":"InSilico Medicine (“the Company”) and China Medical System Holdings Limited (“CMS”) have entered a strategic partnership to pursue AI-driven drug development projects in the fields of central nervous...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"gpt_icon":0},{"id":"1106267413","title":"Insilico Partners with CMS on Multi-Million-Dollar AI-Driven Drug Development for CNS and Autoimmune Disorders","url":"https://stock-news.laohu8.com/highlight/detail?id=1106267413","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106267413?lang=en_us&edition=fundamental","pubTime":"2026-02-10 08:20","pubTimestamp":1770682819,"startTime":"0","endTime":"0","summary":"Insilico (03696) has announced that the group has entered into a strategic drug development collaboration with CMS. Under this partnership, the two companies will engage in a series of AI-enabled...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1593","IE00BGHQDM52.EUR","SG9999015945.SGD","00867","IE00BMCWC346.EUR","BK1191","IE00BVYPNP33.GBP","03696","SG9999004220.SGD","IE00BVYPNQ40.USD","BK1141","IE00BYV24P56.USD","LU2488822045.USD","SG9999015986.USD","SG9999015978.USD","SG9999015952.SGD"],"gpt_icon":0},{"id":"2610667618","title":"Insilico Medicine Cayman Topco startet Milliarden-Kooperation mit CMS zur Entwicklung von Medikamenten für das zentrale Nervensystem und Autoimmunerkrankungen","url":"https://stock-news.laohu8.com/highlight/detail?id=2610667618","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610667618?lang=en_us&edition=fundamental","pubTime":"2026-02-10 08:01","pubTimestamp":1770681703,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Insilico Medicine Cayman Topco published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on February 10, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260210:nNDLbDr1GM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BVYPNQ40.USD","03696","BK1593","IE00BGHQDM52.EUR","IE00BMCWC346.EUR","SG9999015986.USD","SG9999015952.SGD","SG9999015978.USD","BK1141","IE00BYV24P56.USD","00867","IE00BVYPNP33.GBP","SG9999004220.SGD","LU2488822045.USD","SG9999015945.SGD","BK1191"],"gpt_icon":0},{"id":"2610667696","title":"Insilico Medicine Cayman Topco - Deal to Collaborate Across Multiple Projects in Fields of Central Nervous System, Autoimmune Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2610667696","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610667696?lang=en_us&edition=fundamental","pubTime":"2026-02-10 08:00","pubTimestamp":1770681652,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260210:nFWN3Z51DE:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1141","03696"],"gpt_icon":0},{"id":"2610667693","title":"Insilico Medicine Cayman Topco - Also Expected to Receive R+D Funding Support of up to Several Tens of Millions of HKD for Each Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2610667693","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610667693?lang=en_us&edition=fundamental","pubTime":"2026-02-10 08:00","pubTimestamp":1770681652,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260210:nFWN3Z51DE:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1141","03696"],"gpt_icon":0},{"id":"2610633667","title":"Insilico Medicine Cayman Topco - Insilico Medicine and CMS Enter Into Drug Development Collaboration","url":"https://stock-news.laohu8.com/highlight/detail?id=2610633667","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610633667?lang=en_us&edition=fundamental","pubTime":"2026-02-10 08:00","pubTimestamp":1770681652,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260210:nFWN3Z51DE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1141","03696"],"gpt_icon":0},{"id":"2609595962","title":"Insilico Medicine ernennt Halle Zhang zur Vizepräsidentin für klinische Entwicklung in der Onkologie","url":"https://stock-news.laohu8.com/highlight/detail?id=2609595962","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609595962?lang=en_us&edition=fundamental","pubTime":"2026-02-06 21:00","pubTimestamp":1770382853,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Insilico Medicine Cayman Topco published the original content used to generate this news brief via PR Newswire  on February 06, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nNDL74yyKb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696","BK1141"],"gpt_icon":0},{"id":"2609955175","title":"Insilico Medicine Appoints Halle Zhang, Phd (Med), as Vice President, Clinical Development - Oncology","url":"https://stock-news.laohu8.com/highlight/detail?id=2609955175","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609955175?lang=en_us&edition=fundamental","pubTime":"2026-02-06 21:00","pubTimestamp":1770382801,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nTUA5C2TQV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["03696","BK1141"],"gpt_icon":0},{"id":"2609308878","title":"Insilico Medicine nominiert ISM5059 als neuen NLRP3-Hemmer für Entzündungstherapien","url":"https://stock-news.laohu8.com/highlight/detail?id=2609308878","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609308878?lang=en_us&edition=fundamental","pubTime":"2026-02-05 21:01","pubTimestamp":1770296515,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Insilico Medicine Cayman Topco published the original content used to generate this news brief via PR Newswire  on February 05, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260205:nNDL2fYx8C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696","BK1141"],"gpt_icon":0},{"id":"2609230886","title":"Insilico Medicine Nominates ISM5059, the Peripheral-Restricted Nlrp3 Inhibitor as Preclinical Candidate, for the Treatment of Multiple Inflammatory and Metabolism Indications","url":"https://stock-news.laohu8.com/highlight/detail?id=2609230886","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609230886?lang=en_us&edition=fundamental","pubTime":"2026-02-05 21:01","pubTimestamp":1770296514,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260205:nFWN3Z10QU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1141","03696"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":1,"totalSize":86,"code":"91000000","status":"200"}]}}